Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2026)

Indivior Pharmaceuticals has reported Current Taxes for 6 years, with the latest figure at $30.0 million in Q2 2026.

• On a quarterly basis, Current Taxes rose 76.47% year-over-year to $30.0 million in Q2 2026; TTM through Jun 2026 was $30.0 million, a 76.47% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, down 71.43% from the prior year.
• Current Taxes was $30.0 million for Q2 2026 at Indivior Pharmaceuticals, up from $26.0 million in the prior quarter.
• The five-year high for Current Taxes was $30.0 million in Q2 2026, with the low at $2.0 million in Q4 2025.
• Average Current Taxes over 5 years is $12.8 million, with a median of $9.0 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Current Taxes tumbled 71.43% in 2025, then surged 116.67% in 2026.
• Over 5 years, Current Taxes stood at $9.0 million in 2022, then slipped by 11.11% to $8.0 million in 2023, then slipped by 12.5% to $7.0 million in 2024, then sank by 71.43% to $2.0 million in 2025, then jumped by 1400.0% to $30.0 million in 2026.
• The last three Current Taxes figures came in at $30.0 million (Q2 2026), $26.0 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.